Abu Dhabi has taken a major step toward transforming how disease is detected, prevented and treated, with the inauguration of the Abu Dhabi Biobank, a platform that connects biological samples with genomic, lifestyle and clinical data to enable earlier action and more personalised care.
Developed through a strategic partnership between the Department of Health – Abu Dhabi (DoH) and M42, the Abu Dhabi Biobank reflects a shift in how healthcare is delivered moving from treating disease to identifying risk earlier, improving diagnosis, and tailoring interventions.
Dr Noura Al Ghaithi, Undersecretary of the Department of Health – Abu Dhabi (DoH), said: “Healthcare is moving from reacting to disease, to anticipating and preventing it. The Abu Dhabi Biobank enables this shift by connecting data, science and care in a way that directly improves people’s lives. It allows us to detect risks earlier, personalise treatment and deliver better outcomes for our community, while contributing to global progress in medicine.”
&uuid=(email))